Scientists have designed a synthetic antibody called Ichorcumab, which prevents blood-clotting without causing excessive bleeding.
Doctors discovered the antibody occurring naturally in a patient treated for a head injury. Given the degree of anticoagulation caused by the antibody, the patient could have died, but the bleeding stopped normally.
The synthetic antibody could be administered as a drug to prevent strokes and heart attacks, without causing the excessive bleeding associated with other anticoagulants.
Read more at University of Cambridge